BMI View: BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the
sanction-induced currency crisis and high rates of inflation. The rapid depreciation of the rial means that
we expect the value of the market to contract sharply in US dollar ter ..."
BMI View: The influx of Syrian refugees into Lebanon is putting a strain on the healthcare system, which is
unable to meet the additional demand for treatment. Elevated political instability is putting the
pharmaceutical sector at risk in terms of government policy relating to ..."
BMI View: Non-governmental organisations will continue to expand healthcare access in Myanmar - a
boon for the country's pharmaceutical market. However, the country's poor protection of intellectual
property, a weak healthcare system and political instability continues to pose ..."
BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly as
the government sees the sector as key to the diversification of the economy. The medical tourism industry in
particular provides opportunities for both pharmaceutical and med ..."
BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical and
healthcare investment, but is not without flaws. Weaknesses in the country's regulatory regime and drug
pricing concerns will continue to deter multinational interest over o ..."
BMI View: The considerable increase in government health expenditure in 2012 highlights Myanmar's
commitment to improving healthcare. However, there are several barriers to the improvement of medical
services, such as limited funding for healthcare, a lack of basic re ..."
BMI View: The considerable increase in the government's healthcare expenditure highlights Singapore's
commitment to provide better, more affordable healthcare services for its population, particularly the
elderly. The government's aim to further increase its expenditu ..."
BMI View: BMI believes that cost-containment policies will not place significant pressure on healthcare
expenditure in Taiwan. This is because the majority of spending in the medical services sector goes towards
salaries for doctors and nurses, which are difficult to ..."
BMI View: Data released by the Turkish drugmakers association for 2013 sales corresponds with our own
forecasts. We have also modified our pharmaceutical sales forecast for 2014 and beyond to reflect the
volatile exchange rate situation. We now see Turkey's lustre as ..."
BMI View: An ageing population in Hong Kong offers growth opportunities for pharmaceutical firms given
the expected rise in demand for medicines and healthcare services. In addition, we highlight that public
hospitals may not be able to keep up in the rise in demand for healthc ..."